Baxalta

Spinoffs Are Outperforming Parent Companies

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

GE And Other Companies In Transition That Insiders Are Buying

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

GE And Other Companies In Transition That Insiders Are Buying

Short Interest Surges In Illumina And Vertex Pharmaceuticals

Short Sellers Dump Vertex, Load Up On Baxalta

Short Interest Surges In Illumina And Vertex Pharmaceuticals

Short Sellers Dump Vertex, Load Up On Baxalta

Big Biotech In The Earnings Spotlight

Shire Still Confident In Baxalta Transaction Despite Treasury Headwinds

Baxalta Recent News

Baxalta Submits Marketing Application For Adynovi In Europe, Shares Tick Higher

Shire CEO: Baxalta Deal 'Creates Significant Value' And Will Create The World's Leading Rare Disease Company 'By A Wide Margin'

Shire-Baxalta Combination Official, Shareholders Get $18 In Cash And Rest In Shares

Merger Time? Baxalta Shares Rip After Shire Takeover Report

UBS: Baxalta Is A Buy Even If Shire Buyout Doesn't Happen

Report: Shire Close To Acquiring Baxalta, Cites Company's Revised Cash Offer

Is Shire's $34 Billion Baxalta Acquisition Good For Shareholders? Most Think So